On Wednesday, Claus Møller has exited the executive management of Y-mabs, and company’s founder, Thomas Gad, steps in as interim CEO until a replacement has been found. A new chair has also been appointed.
by christopher due karlsson, translated by daniel pedersen
Danish-American biotech firm Y-mabs is on the lookout for a new chief executive as the man in charge up to now, Claus Møller, has announced his departure from the role effective immediately, a company press release announced on Wednesday.
Expres2ion CEO Bent U. Frandsen is one of 3,000 volunteers participating in a phase III trial of Bavarian Nordic’s Covid-19 booster candidate. If the vaccine reaches the market, Expres2ion will be entitled to royalties.